Validations: Continuous Manufacturing & PAT / Real-Time Release

Sampling Design for Control Verification in CM

Sampling Design for Control Verification in CM Sampling Design for Control Verification in Continuous Manufacturing In the evolving landscape of pharmaceutical manufacturing, Continuous Manufacturing (CM) is gaining significant traction for its potential to enhance production efficiency and product quality. Central to the successful implementation of CM is the establishment of a robust sampling design for control verification, particularly when integrating…

Continue Reading Sampling Design for Control Verification in CM

Linking Control Strategy to CPV: KPIs and Escalation Trees

Linking Control Strategy to CPV: KPIs and Escalation Trees Linking Control Strategy to CPV: KPIs and Escalation Trees In the contemporary landscape of pharmaceutical manufacturing, especially with an increasing shift towards continuous manufacturing (CM), the establishment of a well-defined control strategy that integrates with Continuous Process Verification (CPV) is paramount. This tutorial aims to elucidate how to link control strategies…

Continue Reading Linking Control Strategy to CPV: KPIs and Escalation Trees

Equipment Capacity & Bottlenecks: Control Implications

Equipment Capacity & Bottlenecks: Control Implications Equipment Capacity & Bottlenecks: Control Implications Understanding Continuous Manufacturing and Its Importance Continuous manufacturing (CM) has emerged as a groundbreaking approach in pharmaceutical production, fundamentally changing the landscape of drug manufacturing. This paradigm shift is rooted in the pursuit of efficiency, consistency, and quality. Unlike traditional batch manufacturing, which processes materials in discrete batches,…

Continue Reading Equipment Capacity & Bottlenecks: Control Implications

Data Integrity in Control Systems: Audit Trails, Time Sync, and Security

Data Integrity in Control Systems: Audit Trails, Time Sync, and Security Data Integrity in Control Systems: Audit Trails, Time Sync, and Security Introduction to Data Integrity in Pharmaceutical Manufacturing Data integrity is a fundamental requirement in the pharmaceutical industry, particularly in controlled environments utilizing continuous manufacturing and process analytical technology (PAT). Ensuring data integrity is critical for compliance with regulatory…

Continue Reading Data Integrity in Control Systems: Audit Trails, Time Sync, and Security

Spec vs Control Limits: Guardbands and Release Impact

Spec vs Control Limits: Guardbands and Release Impact The advent of continuous manufacturing and process analytical technology (PAT) has necessitated a comprehensive understanding of specification limits, control limits, and the concept of guardbands in the pharmaceutical industry. Particularly with the push towards real-time release testing (RTRT), understanding these parameters is crucial for ensuring compliance with regulatory expectations from authorities such…

Continue Reading Spec vs Control Limits: Guardbands and Release Impact

Networked CM Across Sites: Governance and Standardization

Networked CM Across Sites: Governance and Standardization Networked CM Across Sites: Governance and Standardization Continuous manufacturing (CM) is transforming the pharmaceutical landscape, offering significant benefits in efficiency and product quality. However, to leverage these advancements effectively, a robust governance framework and standardization across sites are essential. This article provides a comprehensive step-by-step guide on establishing best practices in continuous manufacturing,…

Continue Reading Networked CM Across Sites: Governance and Standardization

Control Strategy Documentation: What to Put in the Filing

Control Strategy Documentation: What to Put in the Filing Control Strategy Documentation: What to Put in the Filing Introduction to Control Strategies In the evolving pharmaceutical landscape, especially with the introduction of continuous manufacturing, the essence of a robust control strategy cannot be understated. Control strategies act as a cornerstone in ensuring product quality and consistency in pharmaceutical manufacturing. This…

Continue Reading Control Strategy Documentation: What to Put in the Filing

CM Control Readiness Review: Templates and Gate Criteria

CM Control Readiness Review: Templates and Gate Criteria CM Control Readiness Review: Templates and Gate Criteria Introduction to Continuous Manufacturing and Real-Time Release Testing Continuous manufacturing has emerged as a transformative paradigm in the pharmaceutical industry, allowing for ongoing production and immediate quality assurance through methods such as real-time release testing (RTRT) and process analytical technology (PAT). This transition from…

Continue Reading CM Control Readiness Review: Templates and Gate Criteria

Control Strategy for Blend Uniformity: Real-Time Signals and Actions

Control Strategy for Blend Uniformity: Real-Time Signals and Actions Control Strategy for Blend Uniformity: Real-Time Signals and Actions Continuous manufacturing (CM) is rapidly gaining traction in the pharmaceutical industry, necessitating robust control strategies to ensure blend uniformity and product quality. The integration of process analytical technology (PAT) and real-time release testing (RTRT) into this framework enhances process efficiency and compliance…

Continue Reading Control Strategy for Blend Uniformity: Real-Time Signals and Actions

Throughput Changes in CM: Control Impacts and Re-qualification Triggers

Throughput Changes in CM: Control Impacts and Re-qualification Triggers Throughput Changes in Continuous Manufacturing: Control Impacts and Re-qualification Triggers Continuous Manufacturing (CM) presents a transformative approach for the pharmaceutical industry by enhancing efficiency, flexibility, and a more proactive quality assurance model through methodologies such as Process Analytical Technology (PAT) and Real-Time Release Testing (RTRT). However, changes in throughput can significantly…

Continue Reading Throughput Changes in CM: Control Impacts and Re-qualification Triggers